10 Results for "

GABAA receptors (GABAARs)

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "GABAA receptors (GABAARs)" in MCE Product Catalog:

Cat. No.: HY-107782
CAS No.: 21416-53-5
Purity:  99.92%
Picrotin is an active compound, also is one of the composition of picrotoxin (an antagonist of GABAA receptors (GABAARs) and glycine receptors (GlyRs)). Picrotin has sensitivity for GlyRs with IC50 values range from 5.2 μM to 106 μM. Picrotin can be used for the research of neurotransmission .
loading...
    loading...
Cat. No.: HY-115685
CAS No.: 1216629-00-3
Purity:  99.86%
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

3-Methyl-GABA is a potent GABA aminotransferase activator. 3-Methyl-GABA can fit the binding pocket of GABAA receptor (GABAaR). 3-Methyl-GABA can activate L-glutamic acid decarboxylase (GAD). 3-Methyl-GABA has anticonvulsant activity .
loading...
    loading...
Cat. No.: HY-145257
CAS No.: 1808389-92-5
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

GABAA receptor agent 5 (compound 018) is a potent γ-GABAAR antagonist with an Ki of 0.020 µM. GABAA receptor agent 5 shows γ-GABAAR antagonist activity with low cellular membrane permeability .
loading...
    loading...
Cat. No.: HY-107782R
CAS No.: 21416-53-5
Picrotin (Standard) is the analytical standard of Picrotin. This product is intended for research and analytical applications. Picrotin is an active compound, also is one of the composition of picrotoxin (an antagonist of GABAA receptors (GABAARs) and glycine receptors (GlyRs)). Picrotin has sensitivity for GlyRs with IC50 values range from 5.2 μM to 106 μM. Picrotin can be used for the research of neurotransmission .
loading...
    loading...
Cat. No.: HY-145258
CAS No.: 1808463-81-1
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

GABAA receptor agent 6 (compound 2027) is a potent γ-GABAAR antagonist with an Ki of 0.56 µM. GABAA receptor agent 6 shows γ-GABAAR antagonist activity with low cellular membrane permeability .
loading...
    loading...
Cat. No.: HY-147657
CAS No.: 2413850-54-9
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

GABAA receptor modulator-2 (Compound 20) is selective, orally active α5-GABAAR negative allosteric modulator (NAM) with a Ki of 4.1 nM. GABAA receptor modulator-2 shows high-metabolic stability and good CNS safety .
loading...
    loading...
Cat. No.: HY-145256
CAS No.: 2035203-91-7
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

GABAA receptor agent 4 (compound 1e) is a potent γ-GABAAR antagonist with an Ki of 0.18 µM. GABAA receptor agent 4 efficiently rescues inhibition of T cell proliferation. GABAA receptor agent 4 has the immunomodulatory potential .
loading...
    loading...
Cat. No.: HY-103513
CAS No.: 1236105-75-1
Target:  

GABA Receptor

Research Areas:  

Others

GABAA receptor agent 2 (compound 13) is a compound used to study the structure and orthosteric ligand binding of GABA(A) receptors. The relevant model of GABAA receptor agent 2 can be used to understand the details of orthosteric ligand binding, and a detailed binding mode hypothesis was created through structure-activity relationships with two homologous series of orthosteric GABA(A)R antagonists.
loading...
    loading...
Cat. No.: HY-170903
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

GABAA receptor modulator-3 (compound 3b) is a positive allosteric modulator (PAM). GABAA receptor modulator-3 inhibits α1β3γ2 GABAAR at peak and steady state currents with IC50s of 671 and 64 μM, respectively .
loading...
    loading...
Cat. No.: HY-184478
CAS No.: 3103822-75-6
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

GABAA receptor modulator-14 is an orally active, blood-brain barrier permeable selective positive allosteric modulator (PAM) of extrasynaptic δ-containing GABAA receptors (α4β3δ subtype) with an EC50 of 0.8 μM. GABAA receptor modulator-14 selectively enhances tonic neuronal inhibition by potentiating GABA-evoked currents mediated by extrasynaptic δ-GABAARs, produces rapid sustained antidepressant effects, elevates slow-wave NREM sleep and shows no addiction liability in mice. GABAA receptor modulator-14 can be applied to major depressive disorder (MDD) and comorbid insomnia research .
loading...
    loading...